Skip to main content

STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

STAA Cover Image

What Happened?

Shares of medical lens company STAAR Surgical (NASDAQ: STAA) jumped 6.3% in the afternoon session after the company announced that its board of directors authorized a share repurchase program of up to $50 million. 

In a company press release, the program allows STAAR Surgical to buy back up to $50 million of its common stock over the next twelve months. A share repurchase, or buyback, is when a company purchases its own shares from the market. Buybacks reduce the number of shares outstanding, which can increase earnings per share for remaining shareholders. 

Investors often read a buyback as a sign that management and the board believe the stock is undervalued and that the company has enough cash to return capital to shareholders.

Is now the time to buy STAAR Surgical? Access our full analysis report here, it’s free.

What Is The Market Telling Us

STAAR Surgical’s shares are extremely volatile and have had 35 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The biggest move we wrote about over the last year was 2 months ago when the stock dropped 10.1% on the news that a key industry player warned that changes to some insurance plans could slow U.S. procedure growth, sparking fears of a sector-wide slowdown. The concern was raised by Intuitive Surgical, which noted that shifting insurance coverage could dampen the number of medical procedures performed in the United States. This news has investors worried about near-term demand, not just for one company, but for the entire industry reliant on a steady volume of procedures. 

The warning suggests that even with strong individual company performance, broader healthcare policy and insurance plan adjustments can create significant headwinds.

STAAR Surgical is down 13.5% since the beginning of the year, and at $20.41 per share, it is trading 38.8% below its 52-week high of $33.34 from May 2026. Investors who bought $1,000 worth of STAAR Surgical’s shares 5 years ago would now be looking at only $149.89.

ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.

These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.67
+0.29 (0.12%)
AAPL  341.07
+5.15 (1.53%)
AMD  630.63
+1.37 (0.22%)
BAC  56.70
+0.67 (1.20%)
GOOG  341.08
+2.07 (0.61%)
META  751.66
-25.93 (-3.33%)
MSFT  516.17
+18.24 (3.66%)
NVDA  225.07
+0.49 (0.22%)
ORCL  137.10
-2.44 (-1.75%)
TSLA  372.11
-5.83 (-1.54%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.